Molecular POCT analyzer Mini Dock PM001

for infectious diseasesfor respiratory infectionsfor oxycodone

-The global leading on-site nucleic acid testing device -Concluding test results 2 days earlier than antigen tests -Comprehensive application, expandable for muti-variants detection Pluslife Mini Dock is a rapid molecular detection system for dectecting infectious diseases included COVID-19. Based on the self -developed isothermal molecular detection technology,the Mini Dock is able to provide accurate test results that are comparable to top laboratory PCR tests, while it is easier to use and move around and only takes 15 to 35 mins to conclude the result. -------------------------------------------------------------------------------------------------------- Advantages of molecular testing over antigen testing: Antigen detection can only detect the original concentration of the virus surface protein molecules in the respiratory tract, while Pluslife Mini Dock has consistent capacity for detecting targets with 400 copies/ml of SARS-CoV-2 virus，acheving much higher sensitivity than any antigen tests.According to the load of the virus in the body, the virus can be detected nearly 2 days in advance comparing to antigen tests and the infection can be detected in time to prevent further outspread. -------------------------------------------------------------------------------------------------------- Accroding to the clinical comparative study performed in ilexLab,the lnstitute of Clinical Research in lsrael on February, 2022; the molecular detection system from Pluslife achieves identical results comparing to RT-PCR. Contact us for more details.